The functional assessment of alpinia pricei on metabolic syndrome induced by sucrose-containing drinking water in mice

Phytotherapy Research

Volumn 23, Issue 4, 2009, Pages 558-563

  Chou, Yi Chun ^a   Wang, Sheng Yang ^b   Chen, Gou Chun ^a   Lin, Yu Shen ^a   Chao, Pei Min ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Alpinia pricei; C57BL 6J mice; Metabolic syndrome; Sucrose containing drinking water

Indexed keywords

ADIPONECTIN; ALCOHOL; ALPINIA PRICEI EXTRACT; DRINKING WATER; INSULIN; LEPTIN; LIPID; PLANT EXTRACT; SUCROSE; SUCROSE CONTAINING DRINKING WATER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DIET; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; MALE; MEDICINAL PLANT; METABOLIC SYNDROME X; MOUSE; NONHUMAN; TAIWAN; ALPINIA; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; METABOLISM; SUGAR INTAKE;

ALPINIA PRICEI; MUS; ZINGIBERACEAE;

ADIPONECTIN; ALPINIA; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY SUCROSE; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; SUCROSE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64549083335     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2691     Document Type: Article

References (46)

1. Aguilera AA, Diaz GH, Barcelata ML, Guerrero OA, Ros RM. 2004. Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. J Nutr Biochem 1: 350-357.
2. Ahima RS, Flier JS. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11: 327-332.
3. Ahmed RS, Sharma SB. 1997. Biochemical studies on combined effects of garlic (Allium sativum Linn) and ginger (Zingiber officinale Roscoe) in albino rats. Indian J Exp Biol 35: 841-843.
4. Akhani SP, Vishwakarma SL, Goyal RK. 2004. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type 1 diabetic rats. J Pharm Pharmacol 56: 101-105.
5. Ammon HP, Wahl MA. 1991. Pharmacology of Curcuma longa. Planta Med 57: 1-7.
6. Arita Y, Kihara S, Ouchi N et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
7. Asai A, Miyazawa T. 2001. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131: 2932-2935.
8. Berger JP, Akiyama TE, Meinke PT. 2005. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 26: 244-251.
9. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. 2001. Endogenous glucose production is inhibited by the adipose- derived protein Acrp30. J Clin Invest 108: 1875-1881.
10. DeFronzo RA. 2004. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 143: 9-21.
11. Divya CS, Pillai MR. 2006. Antitumor action of curcumin in human papillomavirus associated cells involves down- regulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 45: 320-332.
12. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. 2000. Development of hypertension in a rat model of diet-induced obesity. Hypertension 35: 1009-1015.
13. El Hafidi M, Cuellar A, Ramirez J, Banos G. 2001. Effect of sucrose addition to drinking water, that induces hypertension in the rats, on liver microsomal Delta9 and Delta5-desaturase activities. J Nutr Biochem 12: 396-403.
14. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. 1993. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058.
15. Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509.
16. Fried SK, Rao SP. 2003. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 78: 873S-880S.
17. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity- induced insulin resistance. Science 271: 665-668.
18. Johnson RJ, Segal MS, Sautin Y et al. 2007. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 86: 899-906.
19. Lagouge M, Argmann C, Gerhart-Hines Z et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122.
20. ymice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. J Nutr 133: 3369-3377.
21. Maffei M, Halaas J, Ravussin E et al. 1995. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161.
22. Mann JI. 2002. Diet and risk of coronary heart disease and type 2 diabetes. Lancet 360: 783-789.
23. Mascolo N, Jain R, Jain SC, Capasso F. 1989. Ethnopharma- cologic investigation of Z. officinale (Zingiber officinale). J Ethnopharmacol 27: 129-140.
24. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K. 1994. Pathophysiology and pathogenesis of visceral fat obesity. Diabetes Res Clin Pract 24: S111-S116.
25. McGarry JD. 2002. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18.
26. ymice. J Agric Food Chem 53: 959-963.
27. Nonn L, Duong D, Peehl DM. 2007. Chemopreventive anti- inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis 28: 1188-1196.
28. Plutzky J. 2000. Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr Opin Cardiol 15: 416-421.
29. Potenza MA, Marasciulo FL, Tarquinio M et al. 2007. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292: E1378-E1387.
30. Prentki M, Corkey BE. 1996. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45: 273-283.
31. Quiles JL, Aguilera C, Mesa MD, Ramirez-Tortosa MC, Baro L, Gil A. 1998. An ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits. Biofactors 8: 51-57.
32. Reaven GM. 1998. Role of insulin resistance on human disease. Diabetes 37: 1595-1607.
33. Sekiya K, Ohtani K, Kusano S. 2004. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors 22: 153-156.
34. Solinas G, Vilcu C, Neels JG et al. 2007. JNK1 in hemato- poietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 6: 386-397.
35. Srimal RC, Dhawan BN. 1973. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25: 447-452.
36. Stanhope KL, Havel PJ. 2008. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19: 16-24.
37. Sumiyoshi M, Sakanaka M, Kimura Y. 2006. Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 136: 582-587.
38. Surwit RS, Feinglos MN, Rodin J et al. 1995. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44: 645-651.
39. Takemura Y, Walsh K, Ouchi N. 2007. Adiponectin and cardiovascular inflammatory responses. Curr Atheroscler Rep 9: 238-243.
40. Tripathi S, Bruch D, Kittur DS. 2008. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med 8: 1.
41. Unger RH. 1995. Lipotoxicity in the pathogenesis of obesity- dependent NIDDM. genetic and clinical implications. Diabetes 44: 863-870.
42. Weber WM, Hunsaker LA, Roybal CN et al. 2006. Activation of NFkB is inhibited by curcumin and related enones. Bioorg Med Chem 14: 2450-2461.
43. Wolfram S. 2007. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26: 373S-388S.
44. Yamauchi T, Kamon J, Waki H et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
45. Yamazaki Y, Kawano Y, Uebayasi M. 2008. Induction of adiponectin by natural and synthetic phenolamides in mouse and human preadipocytes and its enhancement by docosahexaenoic acid. Life Sci 82: 290-300.
46. Zimmet PZ, Alberti KG, Shaw JE. 2005. Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust 183: 175-176.